跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PERINDOPRIL ERBUMINE/INDAPAMIDE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PERINDOPRIL ERBUMINE/INDAPAMIDE
Authorized
STANDARD
PERINDOPRIL ERBUMINE/INDAPAMIDE
PRO DOC LIMITEE
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
39c8b2a5575f4683
Company
PRO DOC LIMITEE
Type
Standard
Approval Details
Approval Id
39c8b2a5575f4683
Drug Approval Canada Name
PERINDOPRIL ERBUMINE/INDAPAMIDE
Product Name
PERINDOPRIL ERBUMINE/INDAPAMIDE
Status
Marketed
Status Date
2023-01-20
Original Market Date
2022-04-01
Din
02523035
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:32.04
Atc Original
C09BA04 PERINDOPRIL AND DIURETICS
Atc Name
c 09 ba 04
Aig Number
0248401001
Company Name
PRO DOC LIMITEE
Company Address
2925 Boulevard Industriel, Laval, Quebec, Canada, H7L 3W9
Active Ingredients
INDAPAMIDE
1.25 MG
PERINDOPRIL ERBUMINE
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
39c8b2a5575f4683
Type
Standard
Back to Health Canada Approvals